Article
Multidisciplinary Sciences
Casper de Boer, Zachary Armstrong, Vincent A. J. Lit, Uri Barash, Gijs Ruijgrok, Ilanit Boyango, Merle M. Weitzenberg, Sybrin P. Schroder, Alexi J. C. Sarris, Nico J. Meeuwenoord, Pedro Bule, Yasmine Kayal, Neta Ilan, Jeroen D. C. Codee, Israel Vlodavsky, Herman S. Overkleeft, Gideon J. Davies, Liang Wu
Summary: Research has shown that by developing effective HPSE inhibitors, extracellular HPSE activity can be reduced, thereby reducing the aggressiveness of cancer and potentially controlling pathological HPSE-driven malignancies.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Oncology
Miriam Gross-Cohen, Sari Feld, Gil Arvatz, Neta Ilan, Israel Vlodavsky
Summary: Hpa2, a close homolog of heparanase, plays a role in a rare genetic disease called urofacial syndrome, indicating its importance in protein coding; despite lacking HS-degrading activity, it shows a high affinity to HS; experimental evidence shows that Hpa2 affects cell adhesion, migration, and colony morphology.
FRONTIERS IN ONCOLOGY
(2021)
Article
Hematology
Raghuram Koganti, Abdullah Memon, Deepak Shukla
Summary: Heparan sulfate is a glycosaminoglycan found in mammalian tissues that contributes to the structural integrity of the extracellular matrix and cell signaling, but is also exploited by viruses during infection. Loss or inhibition of heparan sulfate proteoglycans during infection can lead to significant decreases in viral entry and infectivity, affecting multiple viruses such as herpesviruses, HIV, dengue virus, HPV, and coronaviruses.
SEMINARS IN THROMBOSIS AND HEMOSTASIS
(2021)
Article
Chemistry, Multidisciplinary
Joseph Wakpal, Vishaka Pathiranage, Alice R. Walker, Hien M. Nguyen
Summary: This article describes a method for synthesizing a library of HS mimetics from natural aminoglycosides, reducing the number of steps compared to traditional methods. Computational modeling was used to identify a new class of trisaccharide compounds derived from tobramycin that mimic natural HS and have a strong binding to heparanase but a low affinity for off-target platelet factor-4 protein.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
(2023)
Article
Biochemistry & Molecular Biology
Zuopeng Wu, Rebecca A. Sweet, Gerard F. Hoyne, Charmaine J. Simeonovic, Christopher R. Parish
Summary: It has been accepted for decades that T lymphocytes and metastasising tumour cells traverse basement membranes (BM) by deploying a battery of degradative enzymes, particularly proteases. However, recent studies suggest that there are other mechanisms that allow cell migration through basement membranes.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Neurosciences
Xiao Zhang, Paul O'Callaghan, Honglian Li, Yingxia Tan, Ganlin Zhang, Uri Barash, Xiaomin Wang, Lars Lannfelt, Israel Vlodavsky, Ulf Lindahl, Jin-Ping Li
Summary: Defective clearance of amyloid-beta in the brain, caused by elevated levels of heparanase, results in impaired perivascular drainage and accumulation of A beta, contributing to the pathogenesis of Alzheimer's disease. This study highlights the potential role of heparanase in altering the blood-brain barrier and promoting amyloid-beta accumulation in the brain.
ACTA NEUROPATHOLOGICA COMMUNICATIONS
(2021)
Article
Chemistry, Multidisciplinary
Mohit Chhabra, Gareth G. Doherty, Nicholas W. See, Neha S. Gandhi, Vito Ferro
Summary: Heparan sulfate is a complex polysaccharide widely expressed on cell surfaces and in the extracellular matrix, interacting with numerous proteins to mediate various biological and pathological processes. Developing synthetically tractable HS mimetics with fewer side effects has become an attractive approach for treating cancer and infectious diseases.
Article
Cell Biology
Alyce J. Mayfosh, Katharine J. Goodall, Tien Nguyen, Nikola Baschuk, Mark D. Hulett
Summary: Heparanase is an important enzyme in NK cell cytotoxicity and activation, and its inhibition in clinical trials for metastatic cancer may impact NK cell immunsurveillance.
JOURNAL OF LEUKOCYTE BIOLOGY
(2022)
Article
Cell Biology
Hind Al Khashali, Jadziah Wareham, Ravel Ray, Ben Haddad, Kai-Ling Coleman, Robert Ranzenberger, Patrick McCombs, Jeffrey Guthrie, Deborah Heyl, Hedeel Guy Evans
Summary: This study investigates the roles of heparanase and IGFBP-3 in regulating the survival of non-small-cell lung cancer cells. The results suggest that inhibiting heparanase activity or expression decreases the levels of soluble HS fragments and reduces interactions between IGFBP-3 and HS. Additionally, blocking HA-CD44 signaling increases p53 activity and the levels of IGFBP-3. Silencing p53 leads to increased heparanase levels, while silencing IGFBP-3 blocks p53 activity and increases heparanase levels.
Article
Biochemistry & Molecular Biology
Carina Mucciolo Melo, Helena Bonciani Nader, Giselle Zenker Justo, Maria Aparecida Silva Pinhal
Summary: Heparanase is an enzyme in mammals that cleaves heparan sulfate/heparin chains from proteoglycans. Experiments showed that exogenous heparin can increase Heparanase expression through the Wnt/beta-catenin pathway.
MOLECULAR BIOLOGY REPORTS
(2021)
Article
Medicine, General & Internal
Elisabeth Zechendorf, Katharina Schroeder, Lara Stiehler, Nadine Frank, Christian Beckers, Sandra Kraemer, Michael Dreher, Alexander Kersten, Christoph Thiemermann, Gernot Marx, Tim-Philipp Simon, Lukas Martin
Summary: Heparanase activity and heparan sulfate levels correlate with the severity and outcomes of COVID-19, and may be helpful in predicting clinical progression and outcomes in patients.
JOURNAL OF CLINICAL MEDICINE
(2022)
Review
Biochemistry & Molecular Biology
Alyce J. Mayfosh, Tien K. Nguyen, Mark D. Hulett
Summary: The extracellular matrix plays crucial roles in maintaining tissue structure, immune defense, and acting as a reservoir for bioactive molecules, with heparan sulfate proteoglycans (HSPGs) and their component heparan sulfate being essential in these processes. Understanding the regulation of heparanase and its downstream targets is important for potential therapeutic strategies in inflammatory diseases, atherosclerosis, fibrosis, and cancer metastasis.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Chemistry, Multidisciplinary
Mohit Chhabra, Jennifer C. Wilson, Liang Wu, Gideon J. Davies, Neha S. Gandhi, Vito Ferro
Summary: This study investigates the interaction between Pixatimod and heparanase using a combination of NMR experiments and molecular modeling. The results show that Pixatimod can bind to the active site of heparanase in different conformations, effectively blocking the binding of its natural substrate. This study provides insights for the design of next-generation heparanase inhibitors and substrates.
CHEMISTRY-A EUROPEAN JOURNAL
(2022)
Review
Cell Biology
Tien K. Nguyen, Stephanie Paone, Enoch Chan, Ivan K. H. Poon, Amy A. Baxter, Shane R. Thomas, Mark D. Hulett
Summary: Cardiovascular disease is the leading cause of death and disability worldwide, and atherosclerosis plays a crucial role in its development. Heparanase, as the only mammalian enzyme known to cleave heparan sulfate, has been found to be involved in various physiological and pathological processes, including inflammation and plaque formation. This review focuses on the emerging role of heparanase in atherosclerosis and provides an up-to-date overview of its functions.
Article
Biochemistry & Molecular Biology
Lidan Wu, Na Zhao, Wenjie Jiang, Fengshan Wang
Summary: This study investigated the effects of porcine mucosa-derived heparan sulfate (PMHS) on A beta-induced neurotoxicity in vitro and in vivo. The results showed that PMHS could ameliorate inflammation and apoptosis response in vitro, and improve cognitive impairment and inhibit neuroinflammation and apoptosis in the brain in vivo. Furthermore, PMHS lowered A beta levels by improving the phagocytosis function of neutrophils. This study suggests that PMHS could be developed as a neuroprotective drug for Alzheimer's disease (AD).
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
(2022)
Article
Oncology
Miriam Gross-Cohen, Sari Feld, Ilana Doweck, Gera Neufeld, Peleg Hasson, Gil Arvatz, Uri Barash, Inna Naroditsky, Neta Ilan, Israel Vlodavsky
Article
Cardiac & Cardiovascular Systems
L. Koren, U. Barash, Y. Zohar, N. Karin, A. Aronheim
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2017)
Article
Oncology
Argyris Spyrou, Soumi Kundu, Lulu Haseeb, Di Yu, Tommie Olofsson, Keith Dredge, Edward Hammond, Uri Barash, Israel Vlodavsky, Karin Forsberg-Nilsson
MOLECULAR CANCER THERAPEUTICS
(2017)
Article
Oncology
Uri Barash, Moshe Lapidot, Yaniv Zohar, Cynthia Loomis, Andre Moreira, Sari Feld, Chandra Goparaju, Haining Yang, Edward Hammond, Ganlin Zhang, Jin-Ping Li, Neta Ilan, Arnon Nagler, Harvey I. Pass, Israel Vlodavsky
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2018)
Article
Biochemistry & Molecular Biology
Ilanit Boyango, Uri Barash, Liat Fux, Inna Naroditsky, Neta Ilan, Israel Vlodavsky
Article
Oncology
Uri Barash, Moshe Lapidot, Yaniv Zohar, Cynthia Loomis, Andre Moreira, Sari Feld, Chandra Goparaju, Haining Yang, Edward Hammond, Ganlin Zhang, Jin-Ping Li, Neta Ilan, Arnon Nagler, Harvey I. Pass, Israel Vlodavsky
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2018)
Article
Nanoscience & Nanotechnology
Ravi S. Loka, Eric T. Sletten, Uri Barash, Israel Vlodaysky, Hien M. Nguyen
ACS APPLIED MATERIALS & INTERFACES
(2019)
Article
Oncology
Uri Barash, Argyris Spyrou, Pei Liu, Euvgeni Vlodaysky, Chenchen Zhu, Juanjuan Luo, Dongsheng Su, Neta Ilhan, Karin Forsberg-Nilsson, Israel Vlodaysky, Xiaojun Yang
INTERNATIONAL JOURNAL OF CANCER
(2019)
Article
Oncology
Udayan Bhattacharya, Lilach Gutter-Kapon, Tal Kan, Ilanit Boyango, Uri Barash, Shi-Ming Yang, JingJing Liu, Miriam Gross-Cohen, Ralph D. Sanderson, Yuval Shaked, Neta Ilan, Israel Vlodavsky
Article
Chemistry, Medicinal
Emiliano Esposito, Israel Vlodavsky, Uri Barash, Giuseppe Roscilli, Ferdinando M. Milazzo, Giuseppe Giannini, Annamaria Naggi
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2020)
Article
Biochemistry & Molecular Biology
Svenja Schwarz, Lukas Maria Gockel, Annamaria Naggi, Uri Barash, Martina Gobec, Gerd Bendas, Martin Schlesinger
Article
Oncology
Uri Barash, Shobith Rangappa, Chakrabhavi Dhananjaya Mohan, Divakar Vishwanath, Ilanit Boyango, Basappa Basappa, Israel Vlodavsky, Kanchugarakoppal S. Rangappa
Summary: This study identified a new triazole-thiadiazole-bearing small molecule as a potent inhibitor of heparanase enzymatic activity, cell invasion, experimental metastasis, and tumor growth in mouse models. The findings provide valuable information for further research on the mode of action and clinical significance of triazolo-thiadiazoles in cancer treatment.
Review
Multidisciplinary Sciences
Chakrabhavi Dhananjaya Mohan, Swetha Hari, Habbanakuppe D. Preetham, Shobith Rangappa, Uri Barash, Neta Ilan, S. Chandra Nayak, Vijai K. Gupta, Basappa, Israel Vlodavsky, Kanchugarakoppal S. Rangappa
Article
Oncology
C. P. Baburajeev, Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, Daniel J. Mason, Julian E. Fuchs, Andreas Bender, Uri Barash, Israel Vlodavsky, Basappa, Kanchugarakoppal S. Rangappa